Top 5 Mental Health Apps To Get You Through The Holiday Season
App Reviews /
NeuroFlow Review
Credibility
3.67 / 5.00
Expand Credibility Review
Detailsfor
NeuroFlow
Overall Score: 10/15
Consumer Ratings: 1/2
Clarity of Purpose: 2/2
Mechanism of Action: 1/1
Software Updates: 2/2
Clinical Input in Development: 1/1
Research on Development Process: 1/1
Efficacy of Other Products: 0/1
Research Independence and Review: 2/2
Research Base: 1/3
Rating Date: January 2022
Learn more about the Credibility Rating
User Experience
Not Yet Available
Transparency
Not Yet Available
Professional Review
Not Yet AvailableNeuroFlow aims to help users track and maintain their wellness using principles of cognitive behavioral therapy (CBT). Downloading NeuroFlow requires an invitation from a healthcare provider or specialist. Users are provided a ‘To do list’ of activities to help manage areas they want to improve (ex: sleep, stress, pain, etc). By completing activities, users earn points which can be converted into gift cards. Other tools include ‘Trackers’ for tracking items such as mood and sleep; videos, audio and readings for psychoeducation; a journal; and ‘Crisis Resources’.
Technical Details
Available for iOS 11.0 or later. Compatible with iPhone, iPad, and iPod touch. Android 6.0 and up. Web
Developer: NeuroFlow, Inc.
Type of Treatment: Cognitive Behavioral Principles, Mindfulness, Psychoeducation & Information, Symptom Tracking/Self-Monitoring
Targeted Conditions: Mood Disorders, Stress and Anxiety, Sleep
Target Audience: Not Specified
Designed to be used in conjunction with a professional? Required
Languages Available: English
Cost: Free
Get it on: Apple App Store, Google Play, Web
Research on this App
Commonwealth Pain & Spine Case Study
In one case study, Commonwealth Pain & Spine partnered with NeuroFlow,to be a remote solution for its patients during the COVID-19 pandemic. Through this partnership, Commonwealth tracked patients trends, and used technology to assess needs related to one’s mental and physical health. In this partnership 59% of patients reported a reduction in depression symptoms over 3 months. (https://f.hubspotusercontent20.net/hubfs/5158979/Sales%20Assets%20and%20Collateral/NeuroFlow%20&%20Commonwealth%20Case%20Study.pdf)
Relievus Case Study
In a second case study, Relievus, partnered with Neuroflow to monitor each Relievus patient and lead to more personalized care plans. In 3 months, Relievus was able to onboard 2000+ patients into the platform, who on average, used this platform over 7 times in the first month. Overall, this platform led to 71% of Relievus patients reporting symptom improvement and 44% of the “highest risk” patients showing improvement in their depression and anxiety symptoms in 2 weeks. (https://www.neuroflow.com/case-study-relievus-pain-management/)
